20.700
+15,00%
2026-10-14
Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +4.0% | +110.8% | 3 / 3 | +3.9% | +11.32 pp | +0.01 pp | +31.7% | 0.00 | 3.68 | 360 | +3,9% | 42,1 | +4,0% | 3.68 | 11.75 | −68,7% |
| Pts | 0 | 12 | 12 | 0 | 12 | 8 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 20.700 (close price on 2026-10-14)EPS (TTM): 5.621
Financial charts
1.Revenue & growth
VND bn360Q2/26
1.Revenue & growth
VND bn360Q2/26
2.Profit & growth
VND bn42,1Q2/26
3.Profit mix (Penman)
VND bn265Q2/26
4.Margins & cost structure
%33.4%Q2/26
5.Returns & cash cycle
% · days167%Q2/26
6.Earnings quality & cash
VND bn-379Q2/26
7.Asset structure
VND bn1.055Q2/26
8.Funding & debt health
VND bn · times1.055Q2/26
9.Revenue backlog
VND bn38,7Q2/26
10.Valuation
times · %3,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.117Q2/26
Adjusted EPS growth, latest quarter
4.0%
Average adjusted EPS growth, 3 quarters
111%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26